Drug Topics

JANUARY 23, 2025

Cebranopadol is a first-in-class investigational therapy that targets the nociceptin/orphanin FQ receptor and the -opioid receptor.

360

360

Hospital Pharmacy Europe

JANUARY 23, 2025

Dosing anticancer drugs by body surface area was first introduced in the 1950s, based on preclinical animal models. The rationale was that this metric would better correlate with drug pharmacokinetics and organ function than weight-based dosing. But is it still appropriate in oncology practice today? Professor Alain Astier explains. Body surface area (BSA), calculated using height and weight and expressed in square metres (m), was thought to provide a universal dosing metric applicable across di

Chemotherapy 64

Chemotherapy Hospitals Dosage Pharmaceutical Companies 64

Drug Topics

JANUARY 23, 2025

A discussion with Natalie DiPietro Mager, PharmD, PhD, professor of pharmacy practice at Ohio Northern University.

343

343

Fierce Healthcare

JANUARY 23, 2025

Prime Therapeutics, a PBM owned by Blue Cross plans, violated federal and state antitrust laws through a collaboration with Express Scripts and must pay AIDS Healthcare Foundation more than $10 million, an arbitrator ruled.

138

138

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JANUARY 23, 2025

The new initiative is a way for NCPA to proactively engage its network of community pharmacies during a potential public health crisis.

Community Pharmacies 247

Community Pharmacies 247

Hospital Pharmacy Europe

JANUARY 23, 2025

In a study comparing the performance of multiple trigger tools in identifying medication-related hospital readmissions, the OPERAM tool performed the best, identifying the highest number of both the total medication-related (re)admissions (MRRs) and potential preventable MRRs. Trigger tools are used to identify and measure adverse events over time and recognise MRRs.

Hospitals 52

Hospitals 52

Fierce Healthcare

JANUARY 23, 2025

While the year's 57 Chapter 11 filings didn't reach the highs of 2023, physician practice bankruptcies continue to trend up while hospitals saw their largest bankruptcy "by far in the last 30 years.

Hospitals 131

Hospitals 131

Pharmacy Times

JANUARY 23, 2025

Memantine/donepezil and everolimus are used to treat dementia of the Alzheimer type and tuberous sclerosis complex-associated subependymal giant cell astrocytoma, respectively.

FDA 115

FDA 115

Fierce Healthcare

JANUARY 23, 2025

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's expectations despite decreasing 51% year over year.

116

116

PharmaVoice

JANUARY 23, 2025

Anti-tau candidates haven’t crossed the regulatory threshold like their anti-amyloid counterparts, but J&J’s clinical efforts could lead in the right direction.

113

113

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JANUARY 23, 2025

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. We’ve got lots of news coming out of D.C. today — let’s get straight into it.

106

106

pharmaphorum

JANUARY 23, 2025

This article reflects on the past decade at CES to assess how digital health innovations, including AI, have transformed the healthcare industry.

106

106

Pharmaceutical Technology

JANUARY 23, 2025

The FDA reported that six patients died after being injected with Tevas Copaxone or Sandozs Glatopa.

FDA 105

FDA 105

Fierce Healthcare

JANUARY 23, 2025

More than 24 million people secured coverage during open enrollment on the Affordable Care Act's exchanges, according to the latest marketplace report from CMS.

105

105

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

JANUARY 23, 2025

BioVersys has filed to list on the Swiss Stock Exchange, hoping to raise CHF80m for its novel antibacterial candidates.

103

103

Pharmacy Times

JANUARY 23, 2025

Patients with multiple sclerosis being treated with glatiramer acetate have an increased risk of experiencing anaphylaxis.

FDA 89

FDA 89

pharmaphorum

JANUARY 23, 2025

Tris Pharma has set its sights on an FDA filing for non-opioid pain drug cebranopadol this year after hitting the mark in an abdominoplasty trial.

FDA 100

FDA 100

Pharmacy Times

JANUARY 23, 2025

Approximately 33.2% of patients who received semaglutide 7.2 mg achieved 25% or more weight loss after 72 weeks.

87

87

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

JANUARY 23, 2025

UK study finds adults with ADHD have a big shortfall in life expectancy, raising questions about diagnosis rates and treatment access.

90

90

Pharmacy Times

JANUARY 23, 2025

The Commission aims to provide information for clinical decision making, therapeutic interventions, and public health strategies.

87

87

Outsourcing Pharma

JANUARY 23, 2025

From Novo Holding's purchase of Catalent to BMS's Karuna acquisition, here are 10 of the most significant M&A moments of 2024.

82

82

Pharmacy Times

JANUARY 23, 2025

Despite these findings, navacaprant was generally well-tolerated and safe in patients with major depressive disorder.

81

81

Fierce Healthcare

JANUARY 23, 2025

Centivo, a self-funded health plan for employers, is scaling its virtual care offerings following its acquisition of Eden Health. The company says more members are taking advantage of virtual primary care.

79

79

Pharmacy Times

JANUARY 23, 2025

Stem cell transplantation rates increased the longer patients remained on therapy for myelofibrosis.

Hospitals 73

Hospitals 73

Fierce Healthcare

JANUARY 23, 2025

London-based Neko Health picked up $260 million in fresh funding for its full-body scanning technology, while Solera Health nabbed $40 million and startup Percipio Health launched with $20 million to scale up its smartphone-based population health analytics solution.

74

74

Pharmacy Times

JANUARY 23, 2025

Says the discount card company is colluding with the named PBMs to fix reimbursements

65

65

Fierce Healthcare

JANUARY 23, 2025

The venture builder inked a partnership with Sanabil Investments to open the Sanabil Venture Studio by Redesign Health. The partnership aims to jointly develop and launch at least 20 healthcare companies in the kingdom.

68

68

Pharmacy Times

JANUARY 23, 2025

This case report depicts a probable infusion reaction in a 61-year-old woman prescribed evinacumab for the treatment of familial hypercholesterolemia.

65

65

Pharmaceutical Technology

JANUARY 23, 2025

Viralgen and Axovia are set to form a partnership to progress the development and manufacturing of gene therapy for retinal dystrophy

64

64

Pharmacy Times

JANUARY 23, 2025

The drug is being investigated as a PET diagnostic of cardiac amyloid light-chain and amyloid transthyretin-related (ATTR) amyloidosis.

FDA 62

FDA 62

Pharmafile

JANUARY 23, 2025

Award winners by category DELIVERY AND DEVICE INNOVATION SHL Medical for Elexy reusable electromechanical autoinjector ECO-DESIGN WINNER Huhtamaki for Omnilock Ultra PAPER PACKAGING INNOVATION WINNER Mitsubishi Gas Chemical Company for new OXYCAPT Multilayer Plastic Vial PATIENT-CENTRIC DESIGN WINNER UCB Pharma for Bimzelx 160mg 2ml autoinjectors product for US START-UP INITIATION WINNER Active Label for non-electric […] The post Pharmapack Award Winners 2025 redefining pharmaceutical pack

Packaging 59

Packaging Labelling 59

Pharmaceutical Technology

JANUARY 23, 2025

A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer patients.

59

59

Fierce Healthcare

JANUARY 23, 2025

UnitedHealth Group has named a new CEO for its UnitedHealthcare division nearly two months after the murder of its previous chief executive. | UnitedHealth Group has named a new CEO for its UnitedHealthcare division nearly two months after the murder of its previous chief executive.

57

57